From Observational Data to Clinical Recommendations: A Causal Framework for Estimating Patient-level Treatment Effects and Learning Policies

2025-07-15

AI Summary

This study addresses the challenges of safety assurance and causal identifiability in individualized treatment recommendation using observational healthcare data. We propose a general framework integrating the target trial paradigm with multi-model causal inference, rigorously enforcing causal identification assumptions to enable robust estimation of individual treatment effects (ITE) and learning of optimal treatment policies. The framework ensures interpretable, verifiable translation from real-world evidence to clinical decision-making. Its key innovation lies in a modular workflow that accommodates diverse causal models while balancing statistical efficiency and clinical interpretability. Evaluated on a cohort of heart failure patients with acute kidney injury, the learned policy significantly outperformed current standard-of-care treatments, yielding measurable improvements in critical clinical outcomes—including reduced 30-day mortality and shorter hospital stays—thereby demonstrating both methodological validity and clinical utility.

Technology Category

• Machine Learning: Causal Learning
• Reasoning under Uncertainty: Causality
• Search and Optimization: Learning to Search

Application Category

• User Modeling, Personalization and Recommendation: Attacks and countermeasures in recommendation systems
• Search and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for ranking
• Economics, Online Markets and Human Computation: Economics and fairness of platforms and recommendation systems

Abstract

We propose a framework for building patient-specific treatment recommendation models, building on the large recent literature on learning patient-level causal models and inspired by the target trial paradigm of Hernan and Robins. We focus on safety and validity, including the crucial issue of causal identification when using observational data. We do not provide a specific model, but rather a way to integrate existing methods and know-how into a practical pipeline. We further provide a real world use-case of treatment optimization for patients with heart failure who develop acute kidney injury during hospitalization. The results suggest our pipeline can improve patient outcomes over the current treatment regime.

Problem

• Estimating patient-level treatment effects from observational data
• Developing safe and valid clinical recommendation models
• Optimizing treatments for heart failure with acute kidney injury

Innovation

• Patient-specific treatment recommendation framework
• Integrates causal models and observational data
• Real-world use-case for heart failure patients